Home
About
FAQ
History (1)
Pharmacoeconomic considerations in treating actinic keratosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacoeconomic considerations in treating actinic keratosis.
Neidecker MV, Davis-Ajami ML, Balkrishnan R, Feldman SR. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics. 2009; 27(6):451-64.
View in:
PubMed
subject areas
Cost of Illness
Cost-Benefit Analysis
Economics, Pharmaceutical
Health Care Costs
Humans
Keratosis, Actinic
authors with profiles
Steven R. Feldman MD, PhD